Table 9.11b

Adjusted Patient Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	860	94.1%	0.8%	860	89.1%	1.1%	614	80.9%	1.8%	168	74.2%	4.6%
Primary Diagnosis	Non-Cholestatic Cirrhosis	470	95.3%	1.0%	470	89.5%	1.6%	266	81.5%	2.7%	28	52.9%	10.2%
	Cholestatic Liver Disease/Cirrhosis	149	97.8%	1.3%	149	95.4%	1.8%	88	87.0%	3.6%	8	89.9%	8.7%
	Acute Hepatic Necrosis	42	90.5%	4.6%	42	79.8%	6.8%	41	54.5%	9.8%	13	94.0%	5.6%
	Biliary Atresia	77	90.7%	4.2%	77	89.3%	4.5%	93	82.0%	6.8%	85	90.8%	3.2%
	Metabolic Diseases	24	91.4%	5.7%	24	82.6%	7.8%	28	83.5%	8.7%	13	92.4%	6.9%
	Malignant Neoplasms	44	86.2%	5.2%	44	76.5%	6.5%	52	79.3%	5.7%	2	23.5%	24.1%
	Other	54	88.9%	4.6%	54	88.9%	4.6%	46	79.5%	7.4%	19	70.1%	10.4%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.